SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
27-Feb-18 4:59 PM View: | Elite Pharmaceuticals Inc. (ELTP) | 26-Feb-18 | Grant | 242,060 | $0.12 | $29,991.20 | 7% 3.24M to 3.48M | |
27-Feb-17 6:41 PM View: | Elite Pharmaceuticals Inc. (ELTP) | 23-Feb-17 | Grant | 133,019 | $0.23 | $29,995.80 | 4% 3.11M to 3.24M | |
03-May-16 11:50 AM View: | Elite Pharmaceuticals Inc. (ELTP) | 28-Apr-16 | Conversion | 666,667 | $0.06 | $41,666.70 | 27% 2.44M to 3.11M | |
18-Feb-16 6:56 PM View: | Elite Pharmaceuticals Inc. (ELTP) | 16-Feb-16 | Grant | 122,325 | $0.25 | $29,994.10 | 5% 2.32M to 2.44M | |
09-Mar-15 2:45 PM View: | Elite Pharmaceuticals Inc. (ELTP) | 05-Mar-15 | Grant | 87,711 | $0.34 | $29,997.20 | 4% 2.23M to 2.32M | |
27-Feb-14 5:18 PM View: | Elite Pharmaceuticals Inc. (ELTP) | 25-Feb-14 | Grant | 330,159 | $0.09 | $30,011.50 | 17% 1.9M to 2.23M | |
11-Mar-13 5:50 PM View: | Elite Pharmaceuticals Inc. (ELTP) | 07-Mar-13 | Grant | 230,882 | $0.08 | $18,470.60 | 14% 1.67M to 1.9M | |
13-Dec-12 7:56 AM View: | Elite Pharmaceuticals Inc. (ELTP) | 10-Dec-12 | Market Sale | 201,192 | $0.08 | $15,693.00 | (11%) 1.87M to 1.67M | (92%) |
04-May-12 3:14 PM View: | Elite Pharmaceuticals Inc. (ELTP) | 04-May-12 | Acquisition (other) | 1,355,010 | $0.04 | $50,000.00 | 263% 515.74K to 1.87M | |
27-Mar-12 6:07 PM View: | Elite Pharmaceuticals Inc. (ELTP) | 23-Mar-12 | Market Sale | 200,000 | $0.09 | $18,780.00 | (28%) 715.75K to 515.75K | (79%) |
21-Mar-12 3:57 PM View: | Elite Pharmaceuticals Inc. (ELTP) | 20-Mar-12 | Grant | 289,541 | $0.10 | $28,056.50 | 68% 426.19K to 715.73K | 53% |
16-Mar-11 8:39 PM View: | Elite Pharmaceuticals Inc. (ELTP) | 03-Feb-11 | Private Purchase | 426,192 | $0.04 | $17,047.70 | 100% 0 to 426.19K |